Variable expression of CYP and Pgp genes in the human small intestine
- 6 June 2003
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 33 (6) , 493-499
- https://doi.org/10.1046/j.1365-2362.2003.01154.x
Abstract
Background The small intestine is receiving increased attention for its importance in drug metabolism. However, knowledge of the intervariability and regulation of the enzymes involved, cytochrome P450 and P‐Glycoproteins (CYP and Pgp), is poor when compared with the corresponding hepatic enzymes. Methods The expression of eight different CYP genes and the Pgp were determined by reverse transcription polymerase chain reaction (RT‐PCR) in 51 human duodenum biopsies. And the variability and correlation of expression was analyzed. Results Extensive interindividual variability was found in the expression of most of the genes. Only CYP2C9, CYP3A4 and Pgp were found in all samples. CYP1A2, CYP2A6 and CYP2E1 exhibited the highest interindividual variability. No strong correlation of expression existed between the genes. But a highly significant correlation was found between CYP2D6/1A2, 2D6/2E1, 1A2/2E1 and 2B6/2C9. Acetylsalicylic acid and omeprazole significantly increased the expression of CYPs 2A6, 2E1 and 3A4, respectively. Conclusions Extensive interindividual variability is characteristic for the expression of drug‐metabolizing CYP and Pgp genes in human duodenum, and external factors such as drugs may further increase the variability. It is possible that the large interindividual variability may lead to variable bioavailability of orally used drugs and hence complicate optimal drug therapy, especially for drugs with a small therapeutic window. Elucidation of factors contributing to clinically important variances warrants further investigation.Keywords
This publication has 23 references indexed in Scilit:
- The Mucosa of the Small IntestineClinical Pharmacokinetics, 2002
- Transcriptional Regulation of CYP2C9 GeneJournal of Biological Chemistry, 2002
- The Gut as a Barrier to Drug AbsorptionClinical Pharmacokinetics, 2001
- Human CYP2B6Pharmacogenetics, 1999
- Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.Journal of Clinical Investigation, 1997
- Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug deliveryJournal of Controlled Release, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Induction of hepatic cytochrome P4502E1 in rats by acetylsalicylic acid or sodium salicylateToxicology, 1996
- Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.Journal of Clinical Investigation, 1992
- Regulation of rat hepatic cytochrome P450IIE1 in primary monolayer hepatocyte cultureXenobiotica, 1991